001030251 001__ 1030251
001030251 005__ 20250203133159.0
001030251 0247_ $$2doi$$a10.3390/molecules29163939
001030251 0247_ $$2datacite_doi$$a10.34734/FZJ-2024-05268
001030251 0247_ $$2pmid$$a39203017
001030251 0247_ $$2WOS$$aWOS:001306947000001
001030251 037__ $$aFZJ-2024-05268
001030251 041__ $$aEnglish
001030251 082__ $$a540
001030251 1001_ $$0P:(DE-Juel1)184639$$aCologni, Roberta$$b0
001030251 245__ $$aPreparation and Preclinical Evaluation of 18F-Labeled Olutasidenib Derivatives for Non-Invasive Detection of Mutated Isocitrate Dehydrogenase 1 (mIDH1)
001030251 260__ $$aBasel$$bMDPI$$c2024
001030251 3367_ $$2DRIVER$$aarticle
001030251 3367_ $$2DataCite$$aOutput Types/Journal article
001030251 3367_ $$0PUB:(DE-HGF)16$$2PUB:(DE-HGF)$$aJournal Article$$bjournal$$mjournal$$s1726121809_16073
001030251 3367_ $$2BibTeX$$aARTICLE
001030251 3367_ $$2ORCID$$aJOURNAL_ARTICLE
001030251 3367_ $$00$$2EndNote$$aJournal Article
001030251 500__ $$aThis research was funded by Deutsche Forschungsgemeinschaft (DFG), grant number NE 890/9-1, and by the Helmholtz European Partnering program (‘Innovative high-performance computing approaches for molecular neuromedicine’).
001030251 520__ $$aMutations of isocitrate dehydrogenase 1 (IDH1) are key biomarkers for glioma classification, but current methods for detection of mutated IDH1 (mIDH1) require invasive tissue sampling and cannot be used for longitudinal studies. Positron emission tomography (PET) imaging with mIDH1-selective radioligands is a promising alternative approach that could enable non-invasive assessment of the IDH status. In the present work, we developed efficient protocols for the preparation of four 18F-labeled derivatives of the mIDH1-selective inhibitor olutasidenib. All four probes were characterized by cellular uptake studies with U87 glioma cells harboring a heterozygous IDH1 mutation (U87-mIDH) and the corresponding wildtype cells (U87-WT). In addition, the most promising probe was evaluated by PET imaging in healthy mice and mice bearing subcutaneous U87-mIDH and U87-WT tumors. Although all four probes inhibited mIDH1 with variable potencies, only one of them ([18F]mIDH-138) showed significantly higher in vitro uptake into U87-mIDH compared to U87-WT cells. In addition, PET imaging with [18F]mIDH-138 in mice demonstrated good in vivo stability and low non-specific uptake of the probe, but also revealed significantly higher uptake into U87-WT compared to U87-mIDH tumors. Finally, application of a two-tissue compartment model (2TCM) to the PET data indicated that preferential tracer uptake into U87-WT tumors results from higher specific binding rather than from differences in tracer perfusion. In conclusion, these results corroborate recent findings that mIDH1-selective inhibition may not directly correlate with mIDH1-selective target engagement and indicate that in vivo engagement of wildtype and mutated IDH1 may be governed by factors that are not faithfully reproduced by in vitro assays, both of which could complicate development of PET probes.
001030251 536__ $$0G:(DE-HGF)POF4-5253$$a5253 - Neuroimaging (POF4-525)$$cPOF4-525$$fPOF IV$$x0
001030251 588__ $$aDataset connected to CrossRef, Journals: juser.fz-juelich.de
001030251 7001_ $$0P:(DE-Juel1)131824$$aHolschbach, Marcus$$b1
001030251 7001_ $$0P:(DE-Juel1)156407$$aSchneider, Daniela$$b2
001030251 7001_ $$0P:(DE-Juel1)131810$$aBier, Dirk$$b3
001030251 7001_ $$0P:(DE-Juel1)131847$$aSchulze, Annette$$b4$$ufzj
001030251 7001_ $$0P:(DE-Juel1)156479$$aStegmayr, Carina$$b5
001030251 7001_ $$0P:(DE-Juel1)180330$$aEndepols, Heike$$b6
001030251 7001_ $$0P:(DE-Juel1)131818$$aErmert, Johannes$$b7
001030251 7001_ $$0P:(DE-Juel1)175142$$aNeumaier, Felix$$b8
001030251 7001_ $$0P:(DE-Juel1)166419$$aNeumaier, Bernd$$b9$$eCorresponding author
001030251 773__ $$0PERI:(DE-600)2008644-1$$a10.3390/molecules29163939$$gVol. 29, no. 16, p. 3939 -$$n16$$p3939$$tMolecules$$v29$$x1420-3049$$y2024
001030251 8564_ $$uhttps://juser.fz-juelich.de/record/1030251/files/Invoice_MDPI_molecules-3143277_2429.33EUR.pdf
001030251 8564_ $$uhttps://juser.fz-juelich.de/record/1030251/files/molecules-29-03939-1.pdf$$yOpenAccess
001030251 8564_ $$uhttps://juser.fz-juelich.de/record/1030251/files/molecules-29-03939-1.gif?subformat=icon$$xicon$$yOpenAccess
001030251 8564_ $$uhttps://juser.fz-juelich.de/record/1030251/files/molecules-29-03939-1.jpg?subformat=icon-1440$$xicon-1440$$yOpenAccess
001030251 8564_ $$uhttps://juser.fz-juelich.de/record/1030251/files/molecules-29-03939-1.jpg?subformat=icon-180$$xicon-180$$yOpenAccess
001030251 8564_ $$uhttps://juser.fz-juelich.de/record/1030251/files/molecules-29-03939-1.jpg?subformat=icon-640$$xicon-640$$yOpenAccess
001030251 8564_ $$uhttps://juser.fz-juelich.de/record/1030251/files/Invoice_MDPI_molecules-3143277_2429.33EUR.gif?subformat=icon$$xicon
001030251 8564_ $$uhttps://juser.fz-juelich.de/record/1030251/files/Invoice_MDPI_molecules-3143277_2429.33EUR.jpg?subformat=icon-1440$$xicon-1440
001030251 8564_ $$uhttps://juser.fz-juelich.de/record/1030251/files/Invoice_MDPI_molecules-3143277_2429.33EUR.jpg?subformat=icon-180$$xicon-180
001030251 8564_ $$uhttps://juser.fz-juelich.de/record/1030251/files/Invoice_MDPI_molecules-3143277_2429.33EUR.jpg?subformat=icon-640$$xicon-640
001030251 8767_ $$d2024-08-29$$jZahlung erfolgt$$zInvoice Number 3143277
001030251 909CO $$ooai:juser.fz-juelich.de:1030251$$pdnbdelivery$$popenCost$$pVDB$$pdriver$$pOpenAPC$$popen_access$$popenaire
001030251 9101_ $$0I:(DE-588b)5008462-8$$6P:(DE-Juel1)131824$$aForschungszentrum Jülich$$b1$$kFZJ
001030251 9101_ $$0I:(DE-588b)5008462-8$$6P:(DE-Juel1)156407$$aForschungszentrum Jülich$$b2$$kFZJ
001030251 9101_ $$0I:(DE-588b)5008462-8$$6P:(DE-Juel1)131810$$aForschungszentrum Jülich$$b3$$kFZJ
001030251 9101_ $$0I:(DE-588b)5008462-8$$6P:(DE-Juel1)131847$$aForschungszentrum Jülich$$b4$$kFZJ
001030251 9101_ $$0I:(DE-588b)5008462-8$$6P:(DE-Juel1)156479$$aForschungszentrum Jülich$$b5$$kFZJ
001030251 9101_ $$0I:(DE-588b)5008462-8$$6P:(DE-Juel1)180330$$aForschungszentrum Jülich$$b6$$kFZJ
001030251 9101_ $$0I:(DE-588b)5008462-8$$6P:(DE-Juel1)131818$$aForschungszentrum Jülich$$b7$$kFZJ
001030251 9101_ $$0I:(DE-588b)5008462-8$$6P:(DE-Juel1)175142$$aForschungszentrum Jülich$$b8$$kFZJ
001030251 9101_ $$0I:(DE-588b)5008462-8$$6P:(DE-Juel1)166419$$aForschungszentrum Jülich$$b9$$kFZJ
001030251 9131_ $$0G:(DE-HGF)POF4-525$$1G:(DE-HGF)POF4-520$$2G:(DE-HGF)POF4-500$$3G:(DE-HGF)POF4$$4G:(DE-HGF)POF$$9G:(DE-HGF)POF4-5253$$aDE-HGF$$bKey Technologies$$lNatural, Artificial and Cognitive Information Processing$$vDecoding Brain Organization and Dysfunction$$x0
001030251 9141_ $$y2024
001030251 915pc $$0PC:(DE-HGF)0000$$2APC$$aAPC keys set
001030251 915pc $$0PC:(DE-HGF)0001$$2APC$$aLocal Funding
001030251 915pc $$0PC:(DE-HGF)0002$$2APC$$aDFG OA Publikationskosten
001030251 915pc $$0PC:(DE-HGF)0003$$2APC$$aDOAJ Journal
001030251 915__ $$0StatID:(DE-HGF)0160$$2StatID$$aDBCoverage$$bEssential Science Indicators$$d2023-10-22
001030251 915__ $$0LIC:(DE-HGF)CCBY4$$2HGFVOC$$aCreative Commons Attribution CC BY 4.0
001030251 915__ $$0StatID:(DE-HGF)0113$$2StatID$$aWoS$$bScience Citation Index Expanded$$d2023-10-22
001030251 915__ $$0StatID:(DE-HGF)0700$$2StatID$$aFees$$d2023-10-22
001030251 915__ $$0StatID:(DE-HGF)0510$$2StatID$$aOpenAccess
001030251 915__ $$0StatID:(DE-HGF)0561$$2StatID$$aArticle Processing Charges$$d2023-10-22
001030251 915__ $$0StatID:(DE-HGF)0100$$2StatID$$aJCR$$bMOLECULES : 2022$$d2024-12-16
001030251 915__ $$0StatID:(DE-HGF)0200$$2StatID$$aDBCoverage$$bSCOPUS$$d2024-12-16
001030251 915__ $$0StatID:(DE-HGF)0300$$2StatID$$aDBCoverage$$bMedline$$d2024-12-16
001030251 915__ $$0StatID:(DE-HGF)0501$$2StatID$$aDBCoverage$$bDOAJ Seal$$d2024-04-10T15:26:48Z
001030251 915__ $$0StatID:(DE-HGF)0500$$2StatID$$aDBCoverage$$bDOAJ$$d2024-04-10T15:26:48Z
001030251 915__ $$0StatID:(DE-HGF)0030$$2StatID$$aPeer Review$$bDOAJ : Anonymous peer review$$d2024-04-10T15:26:48Z
001030251 915__ $$0StatID:(DE-HGF)0600$$2StatID$$aDBCoverage$$bEbsco Academic Search$$d2024-12-16
001030251 915__ $$0StatID:(DE-HGF)0030$$2StatID$$aPeer Review$$bASC$$d2024-12-16
001030251 915__ $$0StatID:(DE-HGF)0199$$2StatID$$aDBCoverage$$bClarivate Analytics Master Journal List$$d2024-12-16
001030251 915__ $$0StatID:(DE-HGF)1150$$2StatID$$aDBCoverage$$bCurrent Contents - Physical, Chemical and Earth Sciences$$d2024-12-16
001030251 915__ $$0StatID:(DE-HGF)0150$$2StatID$$aDBCoverage$$bWeb of Science Core Collection$$d2024-12-16
001030251 915__ $$0StatID:(DE-HGF)9900$$2StatID$$aIF < 5$$d2024-12-16
001030251 920__ $$lyes
001030251 9201_ $$0I:(DE-Juel1)INM-5-20090406$$kINM-5$$lNuklearchemie$$x0
001030251 980__ $$ajournal
001030251 980__ $$aVDB
001030251 980__ $$aI:(DE-Juel1)INM-5-20090406
001030251 980__ $$aAPC
001030251 980__ $$aUNRESTRICTED
001030251 9801_ $$aAPC
001030251 9801_ $$aFullTexts